21 May 2013
Keywords: enzon, takes, new, ifn, alfa, into, phase
Article | 07 August 1997
Enzon's long-acting formulation of Schering-Plough's Intron A(interferon alfa-2b) has gone into Phase III trials for hepatitis C virus ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.